Skip to main content
. 2022 Nov 26;22:489. doi: 10.1186/s12876-022-02557-7

Table 4.

Associations between lifestyle risk factors and those who meet the both WHO criteria I and III for SPS

Characteristics Controls (N = 714) Both Criteria (N = 109) Univariate Analysis both Criteria Multivariate Analysis
N (%) N (%) P-value OR (95% CI) P-value
Sex (Female) 404 (57) 70 (64) 0.130 5.74 (2.72–12.10) < 0.001
Age/ Diagnosis Age (years) (median, IQR) 50 (44–55) 36 (30–57.5) < 0.001 0.95 (0.92–0.97) < 0.001
Affected with CRC 0 (0) 24 (22)
Smoking Status
 Never Smoked 334 (47) 46 (43) Ref.
 Current Smoker 121 (17) 12 (11) 0.233 0.80 (0.36–1.78) 0.587
 Former Smoker 258 (36) 50 (46) 0.428 1.68 (0.96–2.93) 0.069
Years Smoked (mean ± S.D.) 10.20 ± 12.43 9.45 ± 13.83 0.568 1.01 (0.99–1.04) 0.306
Daily Cigarettes
 No Cigarettes 334 (47) 51 (49) Ref.
 1–5 Cigarettes per day 54 (8) 20 (19) 0.003 2.35 (1.09–5.05) 0.029
 6–10 Cigarettes per day 78 (11) 15 (14) 0.470 0.92 (0.41–2.12) 0.863
  > 10 Cigarettes per day 246 (35) 19 (18) 0.016 0.67 (0.34–1.30) 0.236
Height (cm) (mean ± S.D.) 168.61 ± 10.11 172.24 ± 9.62 0.001 1.09 (1.05–1.13) < 0.001
Weight (kg) (mean ± S.D.) 75.56 ± 16.94 76.90 ± 15.59
Weight at 20 years of age (kg) (mean ± S.D.) 63.22 ± 12.91 68.28 ± 12.95
BMI at registration (mean ± S.D.) 26.51 ± 5.30 25.80 ± 4.33 0.193
BMI at 20 years of age (mean ± S.D.) 22.14 ± 3.53 22.99 ± 3.63 0.037 1.06 (0.99–1.13) 0.122
Diabetes 31 (4) 7 (7) 0.295
Blood Lipid Lowering Medication 65 (9) 14 (14) 0.148 3.36 (1.36–8.33) 0.009
Weekly Aspirin (dose/week) (mean ± S.D.) 0.99 ± 3.36 0.53 ± 2.08 0.130 0.96 (0.86–1.07) 0.450
Weekly NSAIDs (dose/week) (mean ± S.D.) 1.72 ± 4.62 0.36 ± 1.85 < 0.001 0.88 (0.78–0.99) 0.028
Weekly Antacids (dose/week) (mean ± S.D.) 1.20 ± 4.75 1.33 ± 7.37 0.812
Weekly Multivitamins (dose/week) (mean ± S.D.) 1.79 ± 3.44 1.49 ± 2.99 0.376
Calcium (dose/week) (mean ± S.D.) 1.01 ± 2.70 0.78 ± 2.84 0.393
Paracetamol (dose/week) (mean ± S.D.) 1.86 ± 7.60 2.14 ± 6.68 0.730
Folate (dose/week) (mean ± S.D.) 1.09 ± 2.53 0.27 ± 1.37 < 0.001 0.82 (0.70–0.96) 0.012
Weekly Alcohol Consumption
No Alcohol 171 (27) 28 (31) Ref.
1–100 g per week 285 (46) 33 (37) 0.207 0.39 (0.20–0.75) 0.005
101–200 g per week 100 (16) 21 (23) 0.429 1.09 (0.51–2.34) 0.821
201–350 g per week 46 (7) 5 (6) 0.425 0.54 (0.16–1.82) 0.322
> 350 g per week 25 (4) 3 (3) 0.629 0.16 (0.02–1.43) 0.102
Beer (serves per week) (mean ± S.D.) 1.78 ± 5.44 2.40 ± 6.55 0.437
Wine (serves per week) (mean ± S.D.) 4.09 ± 6.34 2.68 ± 4.81 0.025 0.95 (0.90–1.00) 0.067
Spirits (serves per week) (mean ± S.D.) 1.37 ± 4.34 1.18 ± 3.92 0.680
Number of Pregnancies (mean ± S.D.)a 2.67 ± 1.61 1.58 ± 1.53 < 0.001 0.75 (0.57–0.98) 0.035
Pregnancy Age (years) (mean ± S.D.) a 25.68 ± 4.86 24.81 ± 4.26 0.260
Hormone Replacement Therapy (HRT) a 74 (21) 5 (8) 0.009 0.33 (0.08–1.32) 0.116

In the multivariate models, it was multivariate adjusted. Each group of cases is compared with controls. Variables were included in the multivariate model if it had a p-value of < 0.15 and less than < 20% missing data. A variable was considered significant in the multivariate model if it had a p-value < 0.05. For variables that were highly correlated the smaller p-value was selected as the proxy to be included into the multivariate model.

a female only analysis